The potential role of minimal/molecular residual disease in colorectal cancer: curative surgery, radiotherapy and beyond
{{output}}
Detection of minimal/molecular residual disease (MRD) based on ctDNA assay develops from hematological malignancies to solid tumors. Generally, there are two mainstream assays in MRD testing technology: tumor-informed and tumor-agnostic. For colorectal cancer ... ...
